YYC301

· Yooyoung Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YYC301, covering 2021-05-11 to 2022-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee [Phase 3]